Literature DB >> 21960703

Silent mutation in rpoB detected from clinical samples with rifampin-susceptible Mycobacterium tuberculosis.

Raquel Moure, Rogelio Martín, Fernando Alcaide.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21960703      PMCID： PMC3187328          DOI： 10.1128/JCM.05314-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  3 in total

1.  Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method.

Authors:  Raquel Moure; Laura Muñoz; Miriam Torres; Miguel Santin; Rogelio Martín; Fernando Alcaide
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

2.  Isolation of Mycobacterium tuberculosis strains with a silent mutation in rpoB leading to potential misassignment of resistance category.

Authors:  María Alonso; Juan José Palacios; Marta Herranz; Ana Penedo; Angela Menéndez; Emilio Bouza; Darío García de Viedma
Journal:  J Clin Microbiol       Date:  2011-05-11       Impact factor: 5.948

3.  Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.

Authors:  Catharina C Boehme; Mark P Nicol; Pamela Nabeta; Joy S Michael; Eduardo Gotuzzo; Rasim Tahirli; Ma Tarcela Gler; Robert Blakemore; William Worodria; Christen Gray; Laurence Huang; Tatiana Caceres; Rafail Mehdiyev; Lawrence Raymond; Andrew Whitelaw; Kalaiselvan Sagadevan; Heather Alexander; Heidi Albert; Frank Cobelens; Helen Cox; David Alland; Mark D Perkins
Journal:  Lancet       Date:  2011-04-18       Impact factor: 79.321
  3 in total
  5 in total

Review 1.  Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance.

Authors:  Claudio U Köser; Silke Feuerriegel; David K Summers; John A C Archer; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

Review 2.  Evaluation of the Cepheid Xpert MTB/RIF assay.

Authors:  Thomas M Shinnick; Angela M Starks; Heather L Alexander; Kenneth G Castro
Journal:  Expert Rev Mol Diagn       Date:  2014-11-06       Impact factor: 5.225

3.  Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil.

Authors:  Cinara Silva Feliciano; Lucas José Bazzo Menon; Livia Maria Pala Anselmo; Anzaan Dippenaar; Robin Mark Warren; Wilson Araújo Silva; Valdes Roberto Bollela
Journal:  ERJ Open Res       Date:  2019-08-05

4.  Light Forge: A Microfluidic DNA Melting-based Tuberculosis Test.

Authors:  Ian M Mbano; Tawanda Mandizvo; Jerome Rogich; Tafara T R Kunota; Jared S Mackenzie; Manormoney Pillay; Frederick K Balagaddé
Journal:  J Appl Lab Med       Date:  2020-05-01

5.  Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results.

Authors:  Oksana Ocheretina; Vincent E Escuyer; Marie-Marcelle Mabou; Gertrude Royal-Mardi; Sean Collins; Stalz C Vilbrun; Jean W Pape; Daniel W Fitzgerald
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.